Evidence map›Paper›PMID 40593411›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2025

An Overview of Epitopes and Methods for Antibody Epitope Mapping.

Johan Nilvebrant, Niklas Berndt Thalén, Johan Rockberg, Magdalena Malm

Abstract readReview
PubMed Publisher
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johan NilvebrantSchool of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, AlbaNova University Center, Stockholm, Sweden.
Niklas Berndt ThalénSchool of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, AlbaNova University Center, Stockholm, Sweden.
Johan RockbergSchool of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, AlbaNova University Center, Stockholm, Sweden. johanr@biotech.kth.se.
Magdalena MalmSchool of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, AlbaNova University Center, Stockholm, Sweden. magdalena.malm@biotech.kth.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are protein molecules indispensable for many therapeutic, diagnostic, and research purposes due to their exquisite ability to selectively recognize and bind a given antigen. The particular area of the antigen recognized by the antibody is called the epitope, and mapping of such epitopes can provide important mechanistic insights and indicate for what applications an antibody might be useful. Even though the nature of epitopes can be complex, epitopes in protein antigens are broadly grouped into linear or discontinuous epitopes depending on the positioning of the epitope residues in the antigen sequence and the requirement of structure. Specialized methods for mapping the two different classes of epitopes have been developed. While different in their detail, all of the experimental methods rely on assessing the binding of the antibody to the antigen or a set of antigen mimics. Classical epitope mapping methods, utilizing truncated proteins, small numbers of synthesized peptides, and structural analyses of antibody-antigen complexes, have been significantly refined. Current state-of-the-art methods involve combinations of mutational scanning, protein display, and high throughput screening in conjunction with bioinformatic analyses of large datasets. In line with the significant development of in silico protein structure prediction in recent years, computerized approaches for epitope prediction have also matured considerably.

Indexed as

AntibodiesEpitope MappingEpitopesAnimalsAntigensComputational BiologyHumansAntibodiesAntigensEpitopesAntibodyAntigenEpitopeEpitope mappingPeptidePredictionStructural biology

Identifiers

PMID40593411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.